You are here

Oxford BioTherapeutics

Roche continues ADC dealmaking spree with $1B biobucks pact with Oxford BioTherapeutics

Fierce Biotech

Wed, 03/19/25 - 11:30 am

antibody-drug conjugates

Oxford BioTherapeutics

ADC Space Continues to Thrive with Four More Companies Linking Up

BioSpace

Thu, 06/16/22 - 10:30 am

antibody-drug conjugate

Oxford BioTherapeutics

Oxford BioTherapeutics to research cell therapies for Gilead’s Kite

Pharmaforum

Thu, 01/7/21 - 11:28 am

Gilead Sciences

Oxford BioTherapeutics